Dr. Lei Ge，M.D., Ph.D.

Dr. Lei Ge, M.D., Ph. D., Chief Physician, currently serves as the Deputy Director of the Interventional Cardiology Center at Zhongshan Hospital affiliated to Fudan University. He is a member of the Interventional Cardiology Group under the Chinese Society of Cardiology of the Chinese Medical Association, a training mentor at the Coronary Intervention Training Base of the National Health Commission, and the Deputy Director of the Coronary Intervention Group of the Shanghai Medical Association. He is also a Faculty of the European Society of Cardiology (FESC), a Faculty of the Society for Cardiovascular Angiography and Interventions (FSCAI), a Faculty of the Asia-Pacific Society of Interventional Cardiology (FAPSIC), the Founding Chairman of the Asia-Pacific Chronic Total Occlusion Club (APCTO Club), and the Secretary-General of the China Chronic Total Occlusion Club (CTOCC).

Dr. Ge has long been engaged in the diagnosis and treatment of high-risk and complex coronary heart diseases. He has performed live case demonstrations and delivered specialized academic lectures at numerous domestic and international conferences, including the Shanghai Oriental Congress of Cardiology (OCC), Beijing China Interventional Therapeutics (CIT), European Society of Cardiology Congress (ESC), Transcatheter Cardiovascular Therapeutics (TCT) in the United States, the CTO Summit in the United States, the Complex Cardiovascular Therapeutics (CCT) in Japan, and the CTO Club in Japan. He has participated in multiple research projects, including the Shanghai Municipal Science and Technology Commission’s Key Project: "Experimental Study on Fully Degradable Polylactic Acid Rapamycin Coronary Stents" (as principal investigator), and the National Key Research and Development Program of China: "Animal and Clinical Experimental Study of Fully Degradable Polymer Stents" (as principal investigator).

Dr. Ge has contributed to the writing of several medical works, including "Practical Internal Medicine," "Practical Cardiology," and "Modern Cardiology." He served as the Associate Editor of "Interventional Therapy for Coronary Chronic Total Occlusion" (People's Medical Publishing House), Associate Editor of "Interventional Therapy for Coronary Chronic Total Occlusion 2013" (People's Medical Publishing House), Associate Editor of "Interventional Therapy for Coronary Chronic Total Occlusion 2017" (People's Medical Publishing House), Editor-in-Chief of "Retrograde Interventional Therapy for Coronary Chronic Total Occlusion" (People's Medical Publishing House), Editor-in-Chief of "Interventional Therapy for Coronary Chronic Total Occlusion: Strategies, Techniques, and Case Selection" (Shanghai Scientific & Technical Publishers), and Editor-in-Chief of "Handbook of Interventional Therapy for Coronary Chronic Total Occlusion" (People's Medical Publishing House).Dr. Ge has also published numerous papers in internationally renowned journals such as JACC, JAMA, EHJ, AJC, and Heart. He twice received the Best Paper Award at the Angioplasty Summit in Korea and the Asia-Pacific TCT Conference. He was the first internationally to elucidate the importance of final balloon kissing in the Crush technique for bifurcation lesions and to analyze the efficacy and safety of drug-eluting stents in degenerated saphenous vein grafts. He was among the early researchers to observe the application of drug-eluting stents in chronic total occlusion lesions and to propose the use of electrophysiology mode to reduce radiation exposure during CTO PCI procedures. He has been listed in the Elsevier Highly Cited Chinese Researchers for six consecutive years, with his single most-cited paper receiving 2,214 citations and a total citation count of 15,232.